|
|||||
|
|
Differences in VigiBase® reporting of aminoglycoside and capreomycin‐suspected ototoxicity during tuberculosis treatment |
|
| Authors: | Evans L Sagwa Patrick C Souverein Inês Ribeiro Hubert G M Leufkens Aukje K Mantel‐Teeuwisse |
| Institution: | 1. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;2. Centre for Health Technology Assessment and Drug Research, Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal |
| Abstract: | |
| Keywords: | drug‐resistant tuberculosis hearing loss pharmacoepidemiology pharmacovigilance disproportionality analysis drug safety |